Sirnaomics cleared to start first trial of RNAi lead in cancer

Sirnaomics cleared to start first trial of RNAi lead in cancer

Submitted by admin on August 18, 2018 - 5:14pm
Source: 
Fierce Biotech
News Tags: 
gene silencing
Simaomics
RNAi
STP705
Headline: 
Sirnaomics cleared to start first trial of RNAi lead in cancer
snippet: 

Gene-silencing specialist Sirnaomics has been cleared to start trials of its STP705 drug in bile duct cancer, its first oncology indication.

Do Not Allow Advertisers to Use My Personal information